HB 544 revises health insurance laws, affecting health insurance issuers, covered individuals, and state employees/retirees. It prohibits health insurance issuers from retroactively denying coverage for services that received prior approval, with exceptions for fraud or misrepresentation. The bill also allows biologic therapies to be prescribed to minors under 18, even if FDA-approved only for adults, provided the treatment is medically necessary and supported by peer-reviewed medical literature. Furthermore, it amends provisions for state insurance contracts, detailing conditions under which certain state employees, retirees, and their families, as well as legislators and judges, can continue membership in state group health plans.
HB 607, known as the "Hearing Aid Coverage Act," proposes to expand health insurance coverage for hearing loss. The bill revises current law that mandates coverage only for children, extending this requirement to include individuals of all ages. It achieves this by amending sections 2-18-704 and 33-22-128 of the Montana Code Annotated, which govern mandatory provisions in insurance contracts. This change would require state insurance plans to cover treatment for hearing loss for both children and adults.
Senate Bill 495 eliminates the Tobacco Prevention Advisory Board. The bill repeals the specific section of law that established this board. It also amends existing statute to remove the board from the list of entities funded by state special revenue accounts, which are primarily used for tobacco disease prevention programs and the Children's Health Insurance Program. The direct effect is the dissolution of the advisory board, which previously provided guidance for these programs.
SB 347 revises medical resident licensure laws in Montana, directly affecting individuals undergoing medical training in the state. The bill removes unlicensed trainees from existing licensing exemptions, meaning they will now be required to obtain a license. It also revises definitions, including adding "PGY" (post-graduate year) and defining a "Resident" as someone enrolled in an approved residency program who holds a valid resident license to practice medicine. These changes clarify and update the qualifications and licensing requirements for medical residents.
SB 233 enacts the Interstate Massage Compact, establishing a new multistate licensing program for massage therapists. This compact allows licensed massage therapists to practice in all participating member states with a single multistate license, increasing their professional mobility. It includes provisions for criminal background checks for multistate licensure and creates an interstate commission to administer the compact. The bill aims to improve public access to massage therapy services and enhance regulatory cooperation among states while ensuring public safety.
HB 241 enacts the Psychology Interjurisdictional Compact (PSYPACT), allowing licensed psychologists to provide services across state lines. This bill enables psychologists licensed in a compact state to offer telepsychology services or temporary in-person services (up to 30 days annually) in other compact states without needing separate licenses. It establishes a framework for mutual recognition of licenses, defines requirements for cross-state practice, and creates a system for sharing licensure and disciplinary information among member states. The compact aims to increase public access to psychological services while maintaining regulatory oversight and accountability for psychologists. It directly affects licensed psychologists and their clients across participating states.
This bill makes Montana's community health aide program permanent by removing its previously scheduled expiration date. It directs the Department of Public Health and Human Services to apply for Medicaid coverage for services provided by certified community health aides. The change directly affects community health aides and their patients, particularly in rural and tribal communities, ensuring continued access to essential healthcare services without future legislative renewal.
HB 41 adds gabapentin to Montana's Schedule V list of controlled substances under the "depressants" category. This change directly affects medical providers who prescribe gabapentin (used for nerve pain, seizures, and other conditions), pharmacists who dispense it, and patients using the medication. The bill amends Montana Code § 50-32-232 to explicitly include gabapentin - identified by its chemical name "1-(aminomethyl)cyclohexaneacetic acid" - in Schedule V depressants alongside drugs like pregabalin. This policy update standardizes gabapentin's regulatory classification without altering its medical use or prescribing rules.